Protective effect of α-tocopherol on oxidative stress in experimental pulmonary fibrosis in rats

Cell Biochemistry and Function

Volumn 25, Issue 6, 2007, Pages 633-637

  Deger, Yeter ^a   Yur, Fatmagul ^a   Ertekin, Ali ^a   Mert, Nihat ^a   Dede, Semiha ^a   Mert, Handan ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Free radical; Oxidative stress; Pulmonary fibrosis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BLEOMYCIN; CATALASE; GLUTATHIONE; MALONALDEHYDE; ANTIOXIDANT;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; LUNG FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ANIMAL; CHEMICALLY INDUCED DISORDER; LUNG; MALE; METABOLISM; PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALIA; RATTUS;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BLEOMYCIN; CATALASE; GLUTATHIONE; LUNG; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PULMONARY FIBROSIS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 38449100797     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1362     Document Type: Article

References (41)

1. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990; 259: 159-184.
2. Rahman I, Skwarska E, Henry M, et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med 1999; 27: 60-68.
3. Nagai A, Aoshiba K, Ishihara Y, et al. Administration of alpha 1-proteinase inhibitor ameliorated bleomycin-induced PF in hamsters. Am Rev Respir Dis 1992: 145: 651-656.
4. Taooka Y, Taooka A, Maeda K, Hiyama K, Ishioka S, Yamakido M. Effects of neutrophils elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir 1997; 156: 260-265.
5. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP. Oxidative stress and acute lung injury. Am J Respir Cell and Mol Biol 2003; 29: 427-431.
6. Winklhofer-Roob BM, Rock E, Ribalta J, Shmerling DH, Roob JM. Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies. Mol Aspects Med 2003; 24: 391-402.
7. Wozniak K, Arabski M, Malecka-Panas E, Drzewoski J, Blasiak J. DNA damage in human colonic mucosa cells induced by bleomycin and the protective action of vitamin E. Cell Mol Biol Lett 2004; 79: 31-45.
8. Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann N Y Acad Sci 2000; 899: 44-60.
9. Ozdil S, Bolkent S, Yanardag R, Arda-Pirincci P. Protective effects of ascorbic acid, dl-alpha-tocopherol acetate, and sodium selenate on ethanol-induced liver damage of rats. Biol Trace Elem Res 2004; 97: 149-162.
10. Tas S, Dirican M, Sarandöl E, Serdar Z. The effect of taurine supplementation on oxidative stress in experimental hypothyroidism. Cell Biochem Funct 2004; 24: 153-158.
11. Tsan MF, Danis EH, Vecchio PJ, Rosano CL. Enhancement of intracellular glutathione protects endothelial cells against oxidant damage. Biochem Biophys Res Commun 1985; 127: 270-276.
12. Gong LK, Li XH, Wang H, et al. Effect of feitai on bleomycin-induced pulmonary fibrosis in rats. J Ethnopharmacol 2005; 96: 537-544.
13. Kilinc C, Ozcan O, Karaoz E, Sunguroglu K, Kutluay T, Karaca L. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies. Basic Clin Physiol Pharmacol 1993; 4: 249-269.
14. Takahashi K. Pulmonary fibrosis and antioxidant agents. Nih.Kyo.Shik.Gak Zas 1989; 27: 428-433.
15. Datta NJ, Namasivayam A. In vitro effect of methanol on folate-deficient rat hepatocytes. Drug Alcohol Depend 2003; 71: 87-91.
16. Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population. Thorax 2006; 61: 320-326.
17. Özyurt H, Söǧüt S, Yildirim Z, et al. Inhibitory effect of caffeic acid phenethylester on bleomycin-induced lung fibrosis in rats. Clin Chim Açta 2004; 339: 65-75.
18. Xia E, Rao G, Remmen HV, Heydari AR, Richardson A. Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction. J Nutr 1994; 125: 195-201.
19. Sushil J, Mcvie KR, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539-1543.
20. Gurel A, Coskun O, Armutcu F, Kanter M, Ozen OA. Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies. J Chem Neuroanat 2005; 29: 173-178.
21. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 196: 143-151.
22. Ball CR. Estimation and identification of thiols in rat spleen after cysteine or glutathione treatment, relevance to protection against nitrogen mustards. Biochem Pharmacol 1966; 15: 809-816.
23. Fernandez V, Videla LA. Effect of acute and chronic ethanol ingestion on the content of reduced glutathione of various tissues of the rat. Experientia 1981; 37: 392-394.
24. Peters SA, Kelly FJ. Vitamin E supplementation in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996; 22: 341-345.
25. Özyurt H. The role of free radicals in bleomycin-induced experimental lung fibrosis in rats and effect of caffeic acid phenethyl ester (cape) on the principle mechanisms on fibrosis. University of İnönü. 2002; 66.
26. Caspary WJ, Lanzo DA, Niziak C. Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron. Biochemistry 1982; 21: 334-338.
27. Yildirim Z, Kotuk M, Erdogan H, et al. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res 2006; 40: 27-33.
28. Hay J, Shahzeidi S, Laurent G. Mechanisms of bleomycin-induced lung damage. Arch Toxicol 1991; 65: 81-94.
29. Söǧüt S, Özyurt H, Armutçu F, et al. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 2004; 494: 213-220.
30. Vuokko LK, Paakkö P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004; 569: 1-6.
31. Arslan SO, Zerin M, Vural H, Coskun A. The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 2002; 32: 21-25.
32. Nici L, Santos-Moore A, Kuhn C, Calabresi P. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Cancer 1998; 83: 2008-2014.
33. Filderman AE, Genovese LA, Lazo JS. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochem Pharmacol 1988; 37: 1111-1116.
34. El-Khatib AS. Possible modulatory mole of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin. Chemotherapy 2002; 48: 244-251.
35. Pardol A, Ruiz V, Arreola JL, et al. Bleomycin-induced pulmonary fibrosis is attenuated in G-glutamyl transpeptidase-deficient mice. Am J Respir 2003; 167: 925-932.
36. Serrano-Mollar A, Closa D, Prats N, et al. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003; 138: 1037-1048.
37. Lii CK, Ko YJ, Chiang MT, Sung WC, Hen HW. Effect of dietary vitamin E on antioxidant status and antioxidant enzyme activities in Sprague-Dawley rats. Nutr Cancer 1998; 32: 95-100.
38. Suntres ZE, Shek PN. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 1997; 10: 47-59.
39. Longbottom JE, Martin TD, Edgell KW, Long SE, Plantz MR, Warden BE. Determination of trace elements in water by inductively coupled plasma-mass spectrometry: collaborative study. J A O A C Int 1994; 77: 1004-1023.
40. Giri SN, Blaisdell R, Rucker RB, Wang Q, Hyde DM. Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin. Biochem Mech Environ Health Perspect 1994; 102: 137-148.
41. Card JW, Leeder RG, Racz VJ, Brien JF, Bray TM, Massey TE. Effects of dietary vitamin E supplementation on pulmonary morphology and collagen deposition in amiodarone- and vehicle-treated hamsters. Toxicology 1999; 133: 75-84.